Mana.bio’s founding team (L to R): CTO Roy Nevo, scientific founder Avi Schroeder, CEO Yogev Debbi, and scientific co-founder Kira Radinsky
October 10, 2023 07:00 AM EDTUpdated 03:36 PM
Financing

Ex­clu­sive: An­dreessen Horowitz-backed start­up is us­ing AI to de­sign lipid nanopar­ti­cles that go be­yond the liv­er

Ryan Cross

Senior Science Correspondent

One of the biggest chal­lenges fac­ing ge­net­ic med­i­cines is get­ting them to the right part of the body. Lit­tle balls of fat called lipid nanopar­ti­cles …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times